[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity].
Botulinum toxin A intradetrusor injections have revolutionised the treatment of neurogenic detrusor overactivity. Based on a systematic literature review, the french speaking group of neuro-urology (Genulf) propose clinical guidelines concerning the indications of the first injection.
Perrouin-Verbe
B
B
Service de médecine physique et de réadaptation neurologique, hôpital Saint-Jacques, CHU de Nantes, 85, rue Saint-Jacques, 44093 Nantes cedex, France. brigitte.perrouinverbe@chu-nantes.fr
Ruffion
A
A
Gamé
X
X
Denys
P
P
Kerdraon
J
J
Karsenty
G
G
de Sèze
M
M
Haab
F
F
Saussine
C
C
Soler
J-M
JM
Amarenco
G
G
Chartier-Kastler
E
E
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A